Christian Klein

Person

Bonstetten, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Antigen binding molecules comprising a trimeric TNF family ligand a...
- Patent number 12,202,870
- Issue date Jan 21, 2025
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy of an anti CD20 antibody with a BTK inhibitor
- Patent number 12,186,392
- Issue date Jan 7, 2025
- Ono Pharmaceutical Co., Ltd.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding molecules capable of specific binding to...
- Patent number 12,145,994
- Issue date Nov 19, 2024
- HOFFMANN-LA ROCHE INC.
- Peter Bruenker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
T cell activating bispecific antigen binding molecules
- Patent number 12,139,553
- Issue date Nov 12, 2024
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
T cell activating bispecific antigen binding molecules
- Patent number 12,103,982
- Issue date Oct 1, 2024
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
HER2-targeting antigen binding molecules comprising 4-1BBL
- Patent number 12,065,478
- Issue date Aug 20, 2024
- HOFFMANN-LA ROCHE INC.
- Claudia Ferrara Koller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agonistic CD28 antigen binding molecules targeting Her2
- Patent number 12,049,515
- Issue date Jul 30, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan Gasser
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CAR-T reporter based diagnostic assays to detect tumor antigens in...
- Patent number 12,038,441
- Issue date Jul 16, 2024
- HOFFMANN-LA ROCHE INC.
- Diana Darowski
- G01 - MEASURING TESTING
Information Patent Grant
Therapeutic and diagnostic methods for cancer
- Patent number 12,030,946
- Issue date Jul 9, 2024
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific anti-human CD20/human transferrin receptor antibodies an...
- Patent number 12,030,952
- Issue date Jul 9, 2024
- HOFFMANN-LA ROCHE INC.
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoconjugates
- Patent number 12,023,368
- Issue date Jul 2, 2024
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Universal reporter cell assay for specificity test of novel antigen...
- Patent number 12,000,064
- Issue date Jun 4, 2024
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- G01 - MEASURING TESTING
Information Patent Grant
Trivalent, bispecific antibodies
- Patent number 11,993,642
- Issue date May 28, 2024
- HOFFMANN-LA ROCHE INC.
- Ulrich Brinkmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to HLA-A2/MAGE-A4
- Patent number 11,987,632
- Issue date May 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibodies against CD3EPSILON and ROR1
- Patent number 11,952,421
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Minh Diem Vu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of PD-1-targeted IL-2 variant immunocytokines a...
- Patent number 11,865,082
- Issue date Jan 9, 2024
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to NKG2D
- Patent number 11,827,711
- Issue date Nov 28, 2023
- HOFFMANN-LA ROCHE INC.
- Stefan Dengl
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific HER2 antibodies and methods of use
- Patent number 11,787,873
- Issue date Oct 17, 2023
- HOFFMANN-LA ROCHE INC.
- Rebecca Croasdale-Wood
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Car-t cell assay for specificity test of novel antigen binding moie...
- Patent number 11,788,205
- Issue date Oct 17, 2023
- Christian Klein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bispecific anti-human A-beta/human transferrin receptor antibodies...
- Patent number 11,787,868
- Issue date Oct 17, 2023
- Harald Duerr
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to CD3 and CD19
- Patent number 11,780,920
- Issue date Oct 10, 2023
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding molecules targeting OX40 and FAP
- Patent number 11,780,919
- Issue date Oct 10, 2023
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antibody molecules with antigen-transfected T-cells and...
- Patent number 11,732,052
- Issue date Aug 22, 2023
- Carole Bourquin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...
- Patent number 11,718,680
- Issue date Aug 8, 2023
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antigen binding receptors specific for mutated Fc domains
- Patent number 11,679,127
- Issue date Jun 20, 2023
- HOFFMANN-LA ROCHE INC.
- Kay-Gunnar Stubenrauch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific antigen binding proteins
- Patent number 11,673,945
- Issue date Jun 13, 2023
- HOFFMANN-LA ROCHE INC.
- Sabine Imhof-Jung
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies specific for T-cell activating antigens and a...
- Patent number 11,639,397
- Issue date May 2, 2023
- Roche Glycart AG
- Peter Bruenker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antigen binding molecule for a costimulatory TNF receptor
- Patent number 11,639,394
- Issue date May 2, 2023
- HOFFMANN-LA ROCHE INC.
- Sandra Grau-Richards
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of T cell activating bispecific antigen binding...
- Patent number 11,613,587
- Issue date Mar 28, 2023
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor-targeted agonistic CD28 antigen binding molecules
- Patent number 11,608,376
- Issue date Mar 21, 2023
- HOFFMANN-LA ROCHE INC.
- Guy Georges
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIGEN BINDING RECEPTORS
- Publication number 20240424095
- Publication date Dec 26, 2024
- HOFFMANN-LA ROCHE INC.
- Guozhi CHEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240425616
- Publication date Dec 26, 2024
- Roche Glycart AG
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEW INTERLEUKIN-7 IMMUNOCONJUGATES
- Publication number 20240425561
- Publication date Dec 26, 2024
- HOFFMANN-LA ROCHE INC.
- Alejandro CARPY GUTIERREZ CIRLOS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO HLA-A2/MAGE-A4
- Publication number 20240383987
- Publication date Nov 21, 2024
- HOFFMANN-LA ROCHE INC.
- Tina Weinzierl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEASE-ACTIVATED POLYPEPTIDES
- Publication number 20240376171
- Publication date Nov 14, 2024
- HOFFMANN-LA ROCHE INC.
- Samuele CALABRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM
- Publication number 20240368309
- Publication date Nov 7, 2024
- HOFFMANN-LA ROCHE INC.
- Stephan GASSER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AN...
- Publication number 20240317879
- Publication date Sep 26, 2024
- HOFFMANN-LA ROCHE INC.
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CSF1R AND CD3
- Publication number 20240309092
- Publication date Sep 19, 2024
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD1 ANTIBODIES AND METHODS OF USE
- Publication number 20240294642
- Publication date Sep 5, 2024
- HOFFMANN-LA ROCHE INC.
- JOERG BENZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...
- Publication number 20240287193
- Publication date Aug 29, 2024
- HOFFMANN-LA ROCHE INC.
- Gerulf HAENEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER
- Publication number 20240269277
- Publication date Aug 15, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETERODIMERIC FC DOMAIN ANTIBODIES
- Publication number 20240269176
- Publication date Aug 15, 2024
- HOFFMANN-LA ROCHE INC.
- Diana DAROWSKI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES A...
- Publication number 20240216471
- Publication date Jul 4, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
- Publication number 20240141044
- Publication date May 2, 2024
- HOFFMANN-LA ROCHE INC.
- Oliver AST
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO CD3 and CD19
- Publication number 20240132590
- Publication date Apr 25, 2024
- HOFFMANN-LA ROCHE INC.
- Anne Freimoser-Grundschober
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP
- Publication number 20240117049
- Publication date Apr 11, 2024
- HOFFMANN-LA ROCHE INC.
- Maria AMANN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...
- Publication number 20240109976
- Publication date Apr 4, 2024
- HOFFMANN-LA ROCHE INC.
- Marina Bacac
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES
- Publication number 20240092853
- Publication date Mar 21, 2024
- HOFFMANN-LA ROCHE INC.
- Lorenzo DEHO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPLIT ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDE...
- Publication number 20240082437
- Publication date Mar 14, 2024
- HOFFMANN-LA ROCHE INC.
- Christian KLEIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies binding to NKG2D
- Publication number 20240067734
- Publication date Feb 29, 2024
- HOFFMANN-LA ROCHE INC.
- Stefan DENGL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO GPRC5D
- Publication number 20240067749
- Publication date Feb 29, 2024
- HOFFMANN-LA ROCHE INC.
- GEORG FERTIG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREVENTION OR MITIGATION OF NK CELL ENGAGING AGENT-RELATED ADVERSE...
- Publication number 20240058443
- Publication date Feb 22, 2024
- HOFFMANN-LA ROCHE INC.
- Hélène Cécile HAEGEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES
- Publication number 20240043535
- Publication date Feb 8, 2024
- HOFFMANN-LA ROCHE INC.
- Maria Amann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY EMPLOYING A PD1-LAG3 BISPECIFIC ANTIBODY AND A...
- Publication number 20240002546
- Publication date Jan 4, 2024
- HOFFMANN-LA ROCHE INC.
- Laura Codarri Deak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-LAG3 ANTIBODIES
- Publication number 20240002506
- Publication date Jan 4, 2024
- HOFFMANN-LA ROCHE INC.
- Laura CODARRI DEAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES
- Publication number 20230416366
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Peter BRUENKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES
- Publication number 20230416365
- Publication date Dec 28, 2023
- HOFFMANN-LA ROCHE INC.
- Guy GEORGES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIGEN BINDING RECEPTORS
- Publication number 20230390338
- Publication date Dec 7, 2023
- HOFFMANN-LA ROCHE INC.
- Kay-Gunnar STUBENRAUCH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT METHOD
- Publication number 20230372479
- Publication date Nov 23, 2023
- HOFFMANN-LA ROCHE INC.
- Marina BACAC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES...
- Publication number 20230365702
- Publication date Nov 16, 2023
- HOFFMANN-LA ROCHE INC.
- Harald Duerr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christian Klein

Person

Patents Grantslast 30 patents

Antigen binding molecules comprising a trimeric TNF family ligand a...

Combination therapy of an anti CD20 antibody with a BTK inhibitor

Bispecific antigen binding molecules capable of specific binding to...

T cell activating bispecific antigen binding molecules

T cell activating bispecific antigen binding molecules

HER2-targeting antigen binding molecules comprising 4-1BBL

Agonistic CD28 antigen binding molecules targeting Her2

CAR-T reporter based diagnostic assays to detect tumor antigens in...

Therapeutic and diagnostic methods for cancer

Bispecific anti-human CD20/human transferrin receptor antibodies an...

Immunoconjugates

Universal reporter cell assay for specificity test of novel antigen...

Trivalent, bispecific antibodies

Antibodies binding to HLA-A2/MAGE-A4

Bispecific antibodies against CD3EPSILON and ROR1

Combination therapy of PD-1-targeted IL-2 variant immunocytokines a...

Antibodies binding to NKG2D

Bispecific HER2 antibodies and methods of use

Car-t cell assay for specificity test of novel antigen binding moie...

Bispecific anti-human A-beta/human transferrin receptor antibodies...

Antibodies binding to CD3 and CD19

Bispecific antigen binding molecules targeting OX40 and FAP

Bispecific antibody molecules with antigen-transfected T-cells and...

Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and...

Antigen binding receptors specific for mutated Fc domains

Bispecific antigen binding proteins

Bispecific antibodies specific for T-cell activating antigens and a...

Bispecific antigen binding molecule for a costimulatory TNF receptor

Combination therapy of T cell activating bispecific antigen binding...

Tumor-targeted agonistic CD28 antigen binding molecules

Patents Applicationslast 30 patents

ANTIGEN BINDING RECEPTORS

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

NEW INTERLEUKIN-7 IMMUNOCONJUGATES

ANTIBODIES BINDING TO HLA-A2/MAGE-A4

PROTEASE-ACTIVATED POLYPEPTIDES

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING EPCAM

BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AN...

ANTIBODIES BINDING TO CSF1R AND CD3

ANTI-PD1 ANTIBODIES AND METHODS OF USE

TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AN...

ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER

HETERODIMERIC FC DOMAIN ANTIBODIES

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES A...

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

ANTIBODIES BINDING TO CD3 and CD19

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND...

PH-DEPENDENT MUTANT INTERLEUKIN-2 POLYPEPTIDES

SPLIT ANTIBODIES WHICH BIND TO CANCER CELLS AND TARGET RADIONUCLIDE...

Antibodies binding to NKG2D

ANTIBODIES BINDING TO GPRC5D

PREVENTION OR MITIGATION OF NK CELL ENGAGING AGENT-RELATED ADVERSE...

IMMUNE ACTIVATING Fc DOMAIN BINDING MOLECULES

COMBINATION THERAPY EMPLOYING A PD1-LAG3 BISPECIFIC ANTIBODY AND A...

ANTI-LAG3 ANTIBODIES

ANTI-CD3/ANTI-CD28 BISPECIFIC ANTIGEN BINDING MOLECULES

TUMOR-TARGETED AGONISTIC CD28 ANTIGEN BINDING MOLECULES

ANTIGEN BINDING RECEPTORS

TREATMENT METHOD

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES...